The antiphospholipid syndrome (APS) is diagnosed in patients with recurrent
thromboembolic events and/or pregnancy loss in the presence of persistent laboratory …

Objective. To systematically review and establish the prevalence of antibody positivity in
assays not currently included in the APS classification criteria to detect antibodies directed …

Antiphospholipid syndrome (APS) is an autoimmune disease characterized by thrombosis
and pregnancy morbidity (PM) obstetric events together with persistent high titers of …

Antiphospholipid syndrome (APS) is an autoimmune condition characterized by the
occurrence of thrombosis (arterial and/or venous), often multiple, and/or pregnancy …

Objective A task force of scientists at the International Congress on Antiphospholipid
Antibodies recognized that phosphatidylserine-dependent antiprothrombin antibodies …

Antiphospholipid Syndrome (APS) is an autoimmune disease characterized by arterial
and/or venous thrombosis and/or pregnancy morbidity, associated with circulating …

Background According to criteria for the classification of Systemic Lupus Erythematosus
(SLE), autoimmune hemolytic anemia is one of the disease-defining hematologic disorders …

Background: Anti-phosphatidylserine/prothrombin (aPS/PT) antibodies have begun to be
considered potentional biomarkers for antiphospholipid syndrome (APS). This cohort study …

Objective Antiphospholipid antibodies (aPL) interfere with several physiologic functions of
human trophoblasts, including reducing their ability to migrate, decreasing their production …

Objective. To determine the prevalence and clinical association of anti‐phosphatidylserine/
prothrombin antibodies (aPS/PT) in patients with a history of pregnancy complications …